Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(R)-Clopidogrel bisulfate |
Thieno[3,2-c]pyridine-5(4H)-acetic acid,α-(2-chlorophenyl)-6,7-dihydro-,methyl ester,(αR)-,sulfate (1:1);SR 25989C;(R)-(-)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate bisulfate;(R)-(-)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate;(R)-Clopidogrel bisulfate;(R)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate;1623008-22-9 |
120202-71-3 | Inquiry | |
1-(4,5-Dihydro-2-thiazolyl)-3-azetidinethiol hydrochloride |
3-Azetidinethiol, 1-(4,5-dihydro-2-thiazolyl)-, monohydrochloride;3-Mercapto-1-(1,3-thiazolin-2-yl)azetidine hydrochloride;1-(4,5-Dihydro-2-thiazolyl)-3-azetidinethiol hydrochloride;2-(3-Mercaptoazetidin-1-yl)-2-thiazoline hydrochloride;Side Chain of TebipeneM;TebipeneM Side Chain;TebipenaM Side Chain;1-(4,5-Dihydrothiazol-2-yl)azetidine-3-thiol hydrochloride |
179337-57-6 | Inquiry | |
4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid bis[(1-oxobutoxy)methyl] ester |
Cleviprex Impurity C;Clevidipine Butyrate Impurity;5-((Bis(butyryloxy)methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3;5-((Bis(butyryloxy)Methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid;bis((butyryloxy)Methyl) 4-(2',3'-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3,5-dicarboxylate;Clevidipine Butyrate iMpurity Ⅰ;5-((Bis(butyryloxy)methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3-ca;Clevidipine Butyrate Impurity E |
253597-19-2 | Inquiry | |
4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid monomethyl ester |
4-(2,3-DICHLORO-PHENYL)-2,6-DIMETHYL-1,4-DIHYDRO-PYRIDINE-3,5-DICARBOXYLIC ACID MONOMETHYL ESTER;4-(2,3-Dichlorophenyl)-5-(Methoxycarbonyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid;Clevidipine Butyrate iMpurity Ⅴ;Cleviprex Impurity A;Clevidipine Butyrate impurity A |
105580-45-8 | Inquiry | |
4-(2,3-Dichlorophenyl)-2,6-dimethyl-3,5-pyridinedicarboxylic acid 3-methyl 5-[(1-oxobutoxy)methyl] ester |
Clevidipine Butyrate iMpurity Ⅳ;4-(2,3-Dichlorophenyl)-2,6-dimethyl-3,5-pyridinedicarboxylic acid 3-methyl 5-[(1-oxobutoxy)methyl] ester;H 324/78;Cleviprex Impurity D;Clevidipine Butyrate Impurity H324/78 |
188649-48-1 | Inquiry | |
Almotriptan |
Butanedioic acid,2-hydroxy-,compd. with N,N-dimethyl-5-[(1-pyrrolidinylsulfonyl)methyl]-1H-indole-3-ethanamine (1:1);Butanedioic acid,hydroxy-,compd. with 1-[[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine (1:1);Pyrrolidine,1-[[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]-,hydroxybutanedioate (1:1);LAS 31416 D,L-malate acid;Almotriptan malate;PNU 180638E;Axert;PNU 180638;Almotrip forte |
181183-52-8 | Inquiry | |
alpha-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid hydrochloride |
Thieno[3,2-c]pyridine-5(4H)-acetic acid,α-(2-chlorophenyl)-6,7-dihydro-,hydrochloride (1:1),(αS)-;Thieno[3,2-c]pyridine-5(4H)-acetic acid,α-(2-chlorophenyl)-6,7-dihydro-,hydrochloride,(αS)-;(αS)-α-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid hydrochloride (1:1);(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride |
144750-42-5 | Inquiry | |
Cefbuperazone |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R,3S)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-3-hydroxy-1-oxobutyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,(6R,7S)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-3-hydroxy-1-oxobutyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,[6R-[6α,7α,7(2R*,3S*)]]-;(6R,7S)-7-[[(2R,3S)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-3-hydroxy-1-oxobutyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefbuperazone |
76610-84-9 | Inquiry | |
Clopidogrel Related Compound B |
CLOPIDOGRELRELATEDCOMPOUNDB (20 MG) (METHYL(+/-)-(O-CHLOROPHENYL)-4,5-DIHYDROTHIE-NO[2,3-C]PYRIDINE-6(7H)-ACETATE, HYDROCHLORIDE);Clopidogrel Related Compound B;Methyl (-(o-Chlorophenyl)-4,5-dihydrothieno[3,2-c]pyridine-6(7H)-acetate Hydrochlorid;Methyl (+/-)-(o-Chlorophenyl)-4,5-dihydrothieno[3,2-c]pyridine-6(7H)-acetate Hydrochloride;CLOPIDOGREL RELATED COMPOUND B (20 MG) (METHYL(+/-)-(O-CHLOROPHENYL)-4,5-DIHYDROTHIE-NO[2,3-C]PYRIDINE-6(7H)-ACETATE, HYDROCHLORIDE);Thieno[2,3-c]pyridine-6(5H)-acetic acid, α-(2-chlorophenyl)-4,7-dihydro-, methyl ester, hydrochloride (1:1);Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride;ClopidogrelUSP Related CoMpound B |
144750-52-7 | Inquiry | |
Dabigatran |
β-Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-;N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine;Dabigatran;BIBR 953;BIBR 953ZW |
211914-51-1 | Inquiry | |
Eltrombopag olamine |
[1,1′-Biphenyl]-3-carboxylic acid,3′-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2′-hydroxy-,compd. with 2-aminoethanol (1:2);[1,1′-Biphenyl]-3-carboxylic acid,3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-,compd. with 2-aminoethanol (1:2);SB 497115GR;Eltrombopag olamine;Promacta;Eltrombopag diethanolamine salt;Revolade |
496775-62-3 | Inquiry | |
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester |
ethyl 3-(2-((4-carbamimidoylphenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride;Ethyl 3-(2-((4-carbaMiMidoylphenylaMino)Methyl)-1-Methyl-N-(pyridin-2-yl)-1H-ben;Ethyl 3-(2-((4-carbaMiMidoylphenylaMino)Methyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate;Dabigatran (ethyl ester);Alanine, N-[[2-[[[4-(aMinoiMinoMethyl)phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester;Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-;DabigatranEtexilateMesylateinterMediates-6;ethyl 3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate |
429658-95-7 | Inquiry | |
N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine |
Desethyl Dabigatran Etexilate;Desethyl Pradaxa;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine;Dabigatran Etexilate O-Desethyl Impurity;3-[[2-[[4-[(Z)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid;(E)-3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid |
212321-78-3 | Inquiry | |
O-(1,1-Dimethylethyl)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-D-threonine |
D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid;D-Threonine, O-(1,1-diMethylethyl)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-;O-(1,1-Dimethylethyl)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-D-threonine;(2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)butanoic acid |
79276-23-6 | Inquiry | |
Pradaxa |
β-Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester,methanesulfonate (1:1);β-Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester,monomethanesulfonate;Pradaxa;BIBR 1048MS;Dabigatran etexilate mesylate;Dabigatran etexilate methanesulfonate;593282-20-3 |
872728-81-9 | Inquiry | |
Zoledronic acid |
Phosphonic acid,P,P′-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-;Phosphonic acid,[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-;P,P′-[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis[phosphonic acid];(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid;Zoledronic acid;CGP 42446;Zoledronate;Zometa;1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene-1,1-bisphosphonic acid;ZOL 446;2-(Imidazol-1-yl)-1-hydroxy-1,1′-ethylidenediphosphonic acid;BPH 91;Reclast;Orazol;Aclasta;[1-Hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid;(1-Hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;1-Hydroxy-2-(1-imidazolyl)ethane-1,1-diphosphonic acid |
118072-93-8 | Inquiry |
CONTACT INFORMATION
Sign In for Details